Craniopharyngioma, Child

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
SEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 Years	Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Craniopharyngioma, Child, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Froelich syndrome, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Urogenital Abnormalities, Urogenital Diseases, craniopharyngioma, disorder of sexual differentiation, endocrine system disorder, gonadal disorder, gonadal dysgenesis, hypogonadism, neoplasm, primitive neuroectodermal tumor	Not yet recruiting	Phase 3	2026-09-29	NCT07845994
Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults	Craniopharyngioma, Child, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, craniopharyngioma, neoplasm, primitive neuroectodermal tumor	Recruiting	Phase 2	2026-04-23	NCT05465174
Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical Therapy	Craniopharyngioma, Child, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, craniopharyngioma, neoplasm, primitive neuroectodermal tumor	Enrolling by invitation	Not stated	2026-03-23	NCT03610906

Clinical trials